3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Hepatocellular
42
Parkinson Disease 4, Autosomal Dominant Lewy Body
29
Carcinoma, Renal Cell
26
Endometrial Neoplasms
13
Melanoma
10
Neoplasms
8
Uterine Cervical Neoplasms
7
Cholangiocarcinoma
7
Biliary Tract Neoplasms
7
Liver Neoplasms
6
Thyroid Neoplasms
5
Stomach Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
5
Neuroendocrine Tumors
5
Triple Negative Breast Neoplasms
4
Ovarian Neoplasms
4
Neoplasm Metastasis
4
Esophageal Squamous Cell Carcinoma
4
Colorectal Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Thyroid Carcinoma, Anaplastic
3
Recurrence
3
Kidney Neoplasms
3
Esophageal Neoplasms
3
Diabetes Mellitus, Insulin-Dependent, 12
3
Carcinoma, Adenoid Cystic
3
Breast Neoplasms
3
Brain Neoplasms
3
Adenocarcinoma
3
Vulvar Neoplasms
2
Interventions
Specimen Handling
3
Oxaliplatin
3
Magnetic Resonance Spectroscopy
3
Fluorouracil
3
Radiosurgery
2
Liver Transplantation
2
Gemcitabine
2
Cisplatin
2
Biopsy
2
tislelizumab
1
sacituzumab govitecan
1
gemcitabine-oxaliplatin regimen
1
fludarabine
1
dehydroftorafur
1
binimetinib
1
Tegafur
1
S 1 (combination)
1
Pancreatic Hormones
1
Leucovorin
1
Hydroxychloroquine
1
Cyclophosphamide
1
Cholangiopancreatography, Endoscopic Retrograde
1
Capecitabine
1
3-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Klatskin Tumor
×
lenvatinib
×
1 year
×
Clear all
No trials found.